Another study showed that hypoxic bone marrow mesenchymal cell (BMSC)-derived extracellular vesicles could deliver miR-328-3p to lung cancer cells to target the NF2 gene, which ultimately promoted the invasion, migration and EMT of lung cancer by inhibiting the Hippo pathway 31. The gene discussed is NF2; the disease is lung carcinoma.